Progressive multifocal leukoencephalopathy in patients with sarcoidosis

@article{Jamilloux2014ProgressiveML,
  title={Progressive multifocal leukoencephalopathy in patients with sarcoidosis},
  author={Y. Jamilloux and A. N{\'e}el and M. Lecouffe-Desprets and A. F{\`e}vre and S. Kerever and B. Guillon and D. Bouvry and L. Varron and C{\'e}cile Redares and S. Dominique and Mareille Roux and C. Chapelon-Abric and D. Valeyre and F. Ducray and C. Bernard and C. Broussolle and M. Hamidou and P. S{\`e}ve},
  journal={Neurology},
  year={2014},
  volume={82},
  pages={1307 - 1313}
}
Objective: To describe characteristics, risk factors, and treatment outcome of progressive multifocal leukoencephalopathy (PML) complicating sarcoidosis. Methods: A retrospective chart and literature review was performed. Patients were identified through records from physicians of the Groupe Sarcoïdose Francophone. Each case was compared with 3 controls. Results: Ten cases were found (8 men). The median age at sarcoidosis diagnosis was 34.9 (±6) years. PML and sarcoidosis were diagnosed… Expand
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome in seven patients with sarcoidosis: a critical discussion of treatment and prognosis
TLDR
It is concluded that the combination of PML and sarcoidosis is a diagnostic and therapeutic challenge and the development of IRIS might be an indicator of poor outcome. Expand
Progressive multifocal leukoencephalopathy and sarcoidosis under interleukin 7
TLDR
A challenging case of immune reconstitution with IL7 therapy for PML in sarcoidosis in a patient without evidence for underling PID or previous immunosuppressive therapy is reported. Expand
Progressive multifocal leukoencephalopathy in patients with sarcoidosis
TLDR
A patient with sarcoidosis developing possible progressive multifocal leukoencephalopathy despite 4 negative JC virus CSF PCRs and being treated with mirtazapine and IV immunoglobulin is reported. Expand
An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma
TLDR
Findings verified the case as PML with the second autopsy case report of rituximab‐associated PML in Japan, and pathologists should keep this disease in mind in the differential diagnosis when neural symptoms newly emerge in patients who are treated with these drugs. Expand
Severe infections in sarcoidosis
TLDR
Two patients with biopsy proven sarcoidosis died within the 6 months following infection, due to progressive multifocal leucoencephalopathy, and of peritonitis, and after a median follow-up of 8 years. Expand
Clinical Presentation and Disease Course of 37 Consecutive Cases of Progressive Multifocal Leukoencephalopathy (PML) at a German Tertiary-Care Hospital: A Retrospective Observational Study
TLDR
This interdisciplinary retrospective study describes epidemiology, risk factors, clinical course, and treatment trials in patients with PML at a German tertiary-care hospital. Expand
Clearance of Cerebrospinal Fluid JCV DNA with Mirtazapine in a Patient with Progressive Multifocal Leukoencephalopathy and Sarcoidosis
TLDR
The diagnosis of PML in patients with sarcoidosis is challenging given the overlapping presentation; the use of 5HT2a receptor antagonists deserves further studying in patients needing immunosuppressant drugs to control their dysimmune disease. Expand
Neurosarcoidosis: diagnosis, therapy and biomarkers
TLDR
With immunosuppression, clinical remission of NS occurs in the majority of patients, however, in some others, the disease may still progress, as no permanent cure is yet available. Expand
Cerebellar Involvement in an Immunocompetent Patient Presenting with Progressive Multifocal Leukoencephalopathy
TLDR
The case of an 83-year-old immunocompetent man who presented with severe cerebellar symptoms with an MRI scan suggestive of severe demyelinating disease is described and any occult immunosuppression or malignancy is not identified. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 51 REFERENCES
Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis
TLDR
The diagnostic difficulties considering patients with sarcoidosis and neurological symptoms are stressed and JCV-DNA was successfully demonstrated by PCR in the cerebrospinal fluid as well as in the paraffin-embedded tissue of a stereotactical brain biopsy. Expand
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
TLDR
Natalizumab-associated PML has improved survival compared with PML in other populations and a shorter time from symptom onset to diagnosis and localized disease on MRI at diagnosis were associated with improved survival. Expand
Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia
TLDR
A 72-year-old man presented with acute onset gait instability that progressed to a severe cerebellar syndrome with cognitive decline and greatly improved and remains stable 34 months after onset; the potential role of mirtazapine in the treatment of PML is described. Expand
Progressive multifocal leukoencephalopathy in patients with HIV infection.
TLDR
Progressive multifocal leukoencephalopathy often heralds AIDS and may occur in the absence of significant decline in CD4 lymphocytes, and survival is generally poor, although prolonged survival beyond 1 year is not unusual. Expand
Infratentorial progressive multifocal leukencephalopathy in a patient with pulmonary sarcoidosis
TLDR
This case shows a brainstem/cerebellar manifestation of PML in a patient with sarcoidosis, a demyelinating CNS disease caused by re-activation of a latent JCV, which died of cardiovascular failure 11 months after first neurological symptoms occurred. Expand
Determinants of survival in progressive multifocal leukoencephalopathy
TLDR
The presence of JC virus (JCV)-specific cytotoxic T-lymphocytes (CTL) was associated with a trend toward longer survival in patients with progressive multifocal leukoencephalopathy (PML), which was more pronounced than the impact of CD4 count in HIV+ patients with PML early after diagnosis. Expand
Progressive Multifocal Leukoencephalopathy as the First Manifestation of Occult Sarcoidosis: Case Report and Review of the Literature
TLDR
This is the first published case of PML as the first manifestation of sarcoidosis in the absence of inflammatory hematologic involvement, and a 68-year-old woman without known immune suppression presented with mental status changes over several weeks. Expand
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.
TLDR
Pre- and post-contrast magnetic resonance imaging of brain at this time demonstrated numerous high signal foci throughout both cerebral hemispheres including a lesion of the right geniculate-striate pathway as well as the right midbrain and upper pons. Expand
Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.
TLDR
Cryptococcosis is a significant opportunistic infection during extra-thoracic sarcoidosis, which occurs in one-third of the cases in patients without any treatment; it is not associated to severe CD4 lymphocytopenia and has a good prognosis. Expand
Review of Progressive Multifocal Leukoencephalopathy and Natalizumab
TLDR
PML, a usually fatal neurologic infection, should be considered as a risk factor when using natalizumab, and the treatment of multiple sclerosis patients with natalIZumab is a matter of informed risk, individualized for each multiple sclerosis patient. Expand
...
1
2
3
4
5
...